A 天天基金 链接您与财富 美版材梳理 7 3 = 近期,随着各省份逐渐入冬,全国多地流感活动进入上升期。 机构表示,秋冬季流感高峰到来,有望带动流感疫苗、呼吸 道检测、流感用药、用药终端等细分方向的需求增长。 | 流感疫苗 | 检测服务 | | | --- | --- | --- | | 华兰疫苗 | 仁度生物 九安医疗 | | | 华兰生物 | 达安基因 | 万孚生物 | | 百克生物 | 圣湘生物 | 之江生物 | | 金迪克 | 东方生物 | 英诺特 | | 零售药店 | 流感用药 | | | 益丰药房 | 众生药业 | 华润三九 | | 漱玉平民 | 济川药业 | 特一药业 | | ##十 | NING W | 左阳斗左 | | 八学师 | NAREN THE SEY | | | --- | --- | --- | | -心草 | 方盛制药 | 金石亚药 | | 老百姓 | 健康元 | 自玄山 | | 健之佳 | 康恩贝 | HE | | 基金名称 | 近1年收益 | 成立来收益 | | --- | --- | --- | | 安信医药健康股票A | 51.37% | 49.70% | | 前海开源 ...

【11月25日A股三大指数集体走高，市场成交额增加】11月25日，A股三大指数集体上扬。收盘时，沪 指涨0.87%，报3870点；深证成指涨1.53%；创业板指涨1.77%。全市场成交额达1.83万亿元，较前一增 加858亿元，4300只股票上涨。 盘面上，CPO概念、光通信模块板块爆发，德科立、永鼎股份等多股涨 停；F5G概念拉升，特发信息涨停。流感季提前，流感概念活跃，特一药业等多股涨停；游戏板块走 高，巨人网络涨停；教育股普涨，科德教育20CM涨停。 贵金属、激光雷达、海南及通信设备等板块涨 幅居前。不过，船舶制造板块下挫，江龙船艇跌近10%；水产养殖板块走低，水中渔业跌停；航空机 场、预制菜、转基因等板块跌幅居前。 本文由 AI 算法生成，仅作参考，不涉投资建议，使用风险自担 扫码查看原文 本文由 Al 算法生成,仅作参考,不涉投资建议,使用风险自担 和讯财经 FUL hexun.con 和而不同 迅达天下 ...

11月25日，A股三大指数集体走高，截至收盘，沪指涨0.87%报3870点，深证成指涨1.53%，创业板指涨 1.77%。全市场成交额1.83万亿元，较前一交易日增量858亿元，4300股上涨。 | 名称 | | 最新价 | 涨跌额 | 涨跌幅 | | --- | --- | --- | --- | --- | | 上证指数 | 3 | 3870.02 | +33.26 | +0.87% | | 000001 | | | | | | 深证成指 | no | 12777.31 | +192.23 | +1.53% | | 399001 | | | | | | 创业板指 | | 2980.93 | +51.89 | +1.77% | | 399006 | | | | | | 北证50 | | 1396.84 | +10.80 | +0.78% | | 899050 | | | | | | 科创50 | | 1302.17 | +5.56 | +0.43% | | 000688 | | | | GIMET | 盘面上，CPO概念、光通信模块板块爆发，德科立、永鼎股份等多股涨停；F5G概念拉升，特发信息涨 停；流感概 ...

| 涨幅榜 | 资金净流入 | ５日 涨幅を | | --- | --- | --- | | 教育 | 通信设备 | 电子元器 | | +3.84% | +3.69% | +2.879 | | 贵金属 | 基本金属 | 燃气 | | +2.49% | +2.32% And Van and | +2.229 | 盘面上，CPO概念、光通信模块板块爆发，德科立、永鼎股份等多股涨停；F5G概念拉升，特发信息涨停；流感季提前到来，流感概念活跃，特一药业等多 股涨停；游戏板块走高，巨人网络涨停；教育股普涨，科德教育20CM涨停；贵金属、激光雷达、海南及通信设备等板块涨幅居前。另外，船舶制造板块下 挫，江龙船艇跌近10%；水产养殖板块走低，水中渔业跌停；航空机场、预制菜、转基因等板块跌幅居前。(格隆汇) 格隆汇11月25日｜A股三大指数今日集体走高，截至收盘，沪指涨0.87%报3870点，深证成指涨1.53%，创业板指涨1.77%。全市场成交额1.83万亿元，较前 一交易日增量858亿元，4300股上涨。 | 上证指数 | 深证成指 | 北证5C | | --- | --- | --- | | 3870.02 | 127 ...

盘面上，CPO概念、光模块板块爆发，德科立、等多股涨停；F5G概念拉升，涨停；流感季提前到来，流感概念活跃，等多股涨停；游戏板块走高，涨停； 教育股普涨，科德教育20CM涨停；贵金属、激光雷达、海南及通信设备等板块涨幅居前。另外，船舶制造板块下挫，跌近10%；水产养殖板块走低，水中 渔业跌停；航空机场、预制菜、转基因等板块跌幅居前。(格隆汇) 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明 示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com 格隆汇11月25日｜A股三大指数今日集体走高，截至收盘，沪指涨0.87%报3870点，深证成指涨1.53%，指涨1.77%。全市场成交额1.83万亿元，较前一交易 日增量858亿元，4300股上涨。 | 上证指数 | 深证成指 | 北证5C | | --- | --- | --- | | 3870.02 | 12777.31 | 1396.8 | | +33.26 +0.87% +192.23 +1.53% +10.80 ...

| 上证指数 | 深证成指 | 北证5( | | --- | --- | --- | | 3870.02 | 12777.31 | 1396.8 | | +33.26 +0.87% +192.23 +1.53% +10.80 +0 | | | | 科创20 | 创业板指 | 万得全/ | | 1302.17 | 2980.93 | 6143.6 | | +5.56 +0.43% +51.89 +1.77% +75.51 +1 | | | | 沪深300 | 中证500 | 中证A5( | | 4490.40 | 6954.60 | 5392.9 | | +42.36 +0.95% +85.64 +1.25% +58.60 +1 | | | | 中证1000 | 中证2000 | 中证红和 | | 7249.95 | 3051.71 | 5554.2 | | +93.54 +1.31% +52.45 +1.75% +27.05 +0 | | | | 涨幅榜 | 资金净流入 | 5日涨幅* | | --- | --- | --- | | 教育 | 通信设备 | 电子元器 | | +3.84% | +3.69% | ...

Group 1 - The demand for flu-related medications is rising significantly as the flu season approaches, with several stocks in the sector experiencing price surges [1] - Notable stocks that have reached their daily limit include Jindike, Peking University Medicine, and Te Yi Pharmaceutical, among others [1] - Data from Alibaba Health indicates a more than 500% week-on-week increase in the number of people purchasing antiviral flu medications, with Mabalosavir showing a remarkable over 600% increase [1] Group 2 - Experts warn that the H3N2 strain circulating this year is different from previous years, leading to lower immunity in the population and increased transmission risk [2] - The flu virus is known to undergo antigenic drift, but current strains are still within seasonal levels and do not indicate a stronger evolution of the virus [2] Group 3 - Companies are actively ensuring the supply of flu medications and vaccines in response to rising demand [3] - Dongyang Sunshine, a major supplier of Oseltamivir, reports comprehensive coverage of its products across hospitals, pharmacies, and online platforms, maintaining sufficient inventory [3] - Hualan Biological has noted a significant increase in demand for flu vaccines since October, with plans to enhance market supply and ensure timely delivery through cold chain logistics [3]

Core Insights - The flu season has arrived earlier than expected, leading to increased activity in flu-related stocks in the A-share market [1] - Significant sales increases have been reported for antiviral medications, with Oseltamivir sales up 237% and Mabalaosavir up 180% in the past week [1] Stock Performance - Notable stock movements include: - Yipinhong (一品红) up 13% - Hendi Pharmaceutical (亨迪药业) up nearly 11% - Special One Pharmaceutical (特一药业) and Guangji Pharmaceutical (广济药业) both hitting the 10% daily limit up - Other companies like Hainan Haiyao (海南海药) and Peking University Pharmaceutical (北大医药) also saw significant gains [1][2] - The overall market sentiment is positive, with many flu-related stocks experiencing substantial year-to-date increases, such as: - Yipinhong with a year-to-date increase of 225.09% - Hainan Haiyao with a 75.37% increase [2] Consumer Behavior - Data from Alibaba Health indicates a marked increase in the attention and purchase volume of flu medications over the past two weeks, with a more than 500% week-on-week growth in the number of buyers for antiviral drugs [1] - Mabalaosavir has shown exceptional performance, with a 600% increase in the number of buyers compared to the previous period, reflecting heightened consumer awareness regarding flu prevention and treatment [1]

Group 1 - The core viewpoint of the article highlights a significant surge in flu-related stocks as the flu season begins in China, with notable increases in demand for flu medications [1] - Companies such as Peking University Medicine (000788) experienced a sharp increase, hitting the daily limit, while others like Jindike saw over a 10% rise in stock price [1] - Sales data from Dingdang Kuaiyao on November 22 indicates a substantial increase in the sales of antiviral medications, with Oseltamivir's sales growth rate reaching 237% and Marbofloxacin's increasing by 180% over the past week [1]

Group 1 - President Xi Jinping had a phone call with US President Trump on November 24 [1] - Lei Jun, founder and CEO of Xiaomi Group, invested over 100 million HKD to increase his stake in the company to 23.26% [2] - Xiaomi Group's stock rose by 1.52% to 38.66 HKD after the announcement [2] Group 2 - The People's Bank of China will conduct a 10 billion CNY MLF operation to maintain liquidity in the banking system [3] - Analysts expect a new round of reserve requirement ratio cuts may be implemented around year-end [2] Group 3 - The domestic GPU company Moer Thread launched its IPO with a price of 114.28 CNY per share, attracting significant institutional interest [3] - The offline subscription for Moer Thread's shares saw a subscription multiple of nearly 1600 times, indicating high demand [3] Group 4 - A-shares showed weak rebounds with significant declines in core assets due to three main variables affecting the market [4][5] - Goldman Sachs downgraded Ganfeng Lithium's H-shares to "sell" and lowered lithium price expectations for 2026 by 14% [6] Group 5 - Alibaba's AI assistant Qianwen achieved over 10 million downloads in one week, becoming the fastest-growing AI application [7] - Another AI assistant, Ant Lingguang, reached over 200,000 downloads in six days, surpassing ChatGPT's performance [7] Group 6 - The Chinese Foreign Ministry stated that conditions are not suitable for holding a trilateral meeting with Japan and South Korea [8] - Industrial Fulian's stock faced a significant drop, attributed to market rumors, but the company confirmed its operational plans remain on track [9] Group 7 - Goldman Sachs predicts the Federal Reserve will implement a third consecutive rate cut in December, with two additional cuts expected in 2026 [10] - The market currently anticipates a 69.5% probability of a 25 basis point rate cut in December [10] Group 8 - New 3D printing materials developed by the University of Virginia show potential for applications in solid-state batteries and medical technologies [12] - The global 3D printing market is projected to reach 115 billion USD by 2030, with a compound annual growth rate of approximately 30% [12] Group 9 - Dragon Power Technology signed a significant contract worth over 45 billion CNY [18] - Antai Technology secured a key order worth nearly 70 million CNY related to controllable nuclear fusion [18]